Keywords
Diagnosis Clinical Laboratory Technique Treatment Outcome Hepatitis C Virus Hemodialysis Unit
References
-
1.
Ebrahimi Daryani N, Alavian SM, Somi MH, Torabi-Nami M. Hepatitis C and Why the Treatment is Needed Now? The Summary Report From the Cross-Border Symposium of the 5th Tehran Hepatitis Congress May 2013. Hepatitis Monthly. 2013;13(11). https://doi.org/10.5812/hepatmon.16082.
-
2.
Bokharaei-Salim F, Keyvani H, Monavari SH, Alavian SM, Madjd Z, Toosi MN, et al. Occult hepatitis C virus infection in Iranian patients with cryptogenic liver disease. J Med Virol. 2011;83(6):989-95. [PubMed ID: 21503911]. https://doi.org/10.1002/jmv.22044.
-
3.
Carreno V, Bartolome J, Castillo I, Quiroga JA. New perspectives in occult hepatitis C virus infection. World J Gastroenterol. 2012;18(23):2887-94. [PubMed ID: 22736911]. https://doi.org/10.3748/wjg.v18.i23.2887.
-
4.
Barril G, Castillo I, Arenas MD, Espinosa M, Garcia-Valdecasas J, Garcia-Fernandez N, et al. Occult hepatitis C virus infection among hemodialysis patients. J Am Soc Nephrol. 2008;19(12):2288-92. [PubMed ID: 18684893]. https://doi.org/10.1681/ASN.2008030293.
-
5.
Alavian SM. Diabetes, renal failure and hepatitis C infection: The puzzle should be attended more in future. Nephro-Urol Mon. 2011;3(3):153-4.
-
6.
Castillo I, Bartolome J, Quiroga JA, Barril G, Carreno V. Long-term virological follow up of patients with occult hepatitis C virus infection. Liver Int. 2011;31(10):1519-24. [PubMed ID: 22093326]. https://doi.org/10.1111/j.1478-3231.2011.02613.x.
-
7.
Pardo M, Lopez-Alcorocho JM, Castillo I, Rodriguez-Inigo E, Perez-Mota A, Carreno V. Effect of anti-viral therapy for occult hepatitis C virus infection. Aliment Pharmacol Ther. 2006;23(8):1153-9. [PubMed ID: 16611276]. https://doi.org/10.1111/j.1365-2036.2006.02886.x.